Cargando…

Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection

BACKGROUND: Drug-resistant Acinetobacter baumannii has become a major problem in liver transplant recipients. The aim of this study was to investigate the clinical presentation, distribution, and drug susceptibility characteristics in liver recipients with A. baumannii infection. METHODS: We retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Fei, Ye, Qifa, Wan, Qiquan, Liu, Shan, Zhou, Jiandang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381901/
https://www.ncbi.nlm.nih.gov/pubmed/25848296
http://dx.doi.org/10.2147/TCRM.S82251
_version_ 1782364530186125312
author Gao, Fei
Ye, Qifa
Wan, Qiquan
Liu, Shan
Zhou, Jiandang
author_facet Gao, Fei
Ye, Qifa
Wan, Qiquan
Liu, Shan
Zhou, Jiandang
author_sort Gao, Fei
collection PubMed
description BACKGROUND: Drug-resistant Acinetobacter baumannii has become a major problem in liver transplant recipients. The aim of this study was to investigate the clinical presentation, distribution, and drug susceptibility characteristics in liver recipients with A. baumannii infection. METHODS: We retrospectively investigated 17 liver recipients who developed A. baumannii infection between January 1, 2007 and December 31, 2014. The distribution of A. baumannii and drug susceptibility characteristics were reviewed. RESULTS: Infectious complications due to A. baumannii appeared in 17 liver recipients, with a total of 24 episodes. Approximately 63% (15/24) of A. baumannii infections occurred within 2 weeks after transplantation. The most common source of infection was multiple culture-positive sites (35.3%, n=6), followed by the intra-abdominal/biliary tract (23.5%, n=4) and lung (23.5%, n=4). Eight patients (47.1%) had a body temperature of 38°C or higher at the onset of A. baumannii infection. Nine, seven, and 12 recipients had a serum creatinine level of >1.5 mg/dL, a white blood cell count of >15,000/mm(3), and a platelet count of <50,000/mm(3), respectively. There were five (29.4%) cases of septic shock and eight (47.1%) deaths. The rate of antibiotic resistance of A. baumannii to ten of 12 antibiotics investigated was more than 60%. Among the 24 infections caused by A. baumannii, 75% were carbapenem-resistant. The rods were relatively sensitive to tigecycline and cefoperazone-sulbactam. CONCLUSION: The clinical manifestations of A. baumannii infection included a high body temperature, a decreased platelet count, an elevated white blood cell count, and onset in the early period after transplantation as well as high mortality. The antibiotic resistance rate of A. baumannii was extremely high. Prevention measures and combination antibiotic therapy are needed to improve the outcomes of liver recipients with A. baumannii infections.
format Online
Article
Text
id pubmed-4381901
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43819012015-04-06 Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection Gao, Fei Ye, Qifa Wan, Qiquan Liu, Shan Zhou, Jiandang Ther Clin Risk Manag Original Research BACKGROUND: Drug-resistant Acinetobacter baumannii has become a major problem in liver transplant recipients. The aim of this study was to investigate the clinical presentation, distribution, and drug susceptibility characteristics in liver recipients with A. baumannii infection. METHODS: We retrospectively investigated 17 liver recipients who developed A. baumannii infection between January 1, 2007 and December 31, 2014. The distribution of A. baumannii and drug susceptibility characteristics were reviewed. RESULTS: Infectious complications due to A. baumannii appeared in 17 liver recipients, with a total of 24 episodes. Approximately 63% (15/24) of A. baumannii infections occurred within 2 weeks after transplantation. The most common source of infection was multiple culture-positive sites (35.3%, n=6), followed by the intra-abdominal/biliary tract (23.5%, n=4) and lung (23.5%, n=4). Eight patients (47.1%) had a body temperature of 38°C or higher at the onset of A. baumannii infection. Nine, seven, and 12 recipients had a serum creatinine level of >1.5 mg/dL, a white blood cell count of >15,000/mm(3), and a platelet count of <50,000/mm(3), respectively. There were five (29.4%) cases of septic shock and eight (47.1%) deaths. The rate of antibiotic resistance of A. baumannii to ten of 12 antibiotics investigated was more than 60%. Among the 24 infections caused by A. baumannii, 75% were carbapenem-resistant. The rods were relatively sensitive to tigecycline and cefoperazone-sulbactam. CONCLUSION: The clinical manifestations of A. baumannii infection included a high body temperature, a decreased platelet count, an elevated white blood cell count, and onset in the early period after transplantation as well as high mortality. The antibiotic resistance rate of A. baumannii was extremely high. Prevention measures and combination antibiotic therapy are needed to improve the outcomes of liver recipients with A. baumannii infections. Dove Medical Press 2015-03-26 /pmc/articles/PMC4381901/ /pubmed/25848296 http://dx.doi.org/10.2147/TCRM.S82251 Text en © 2015 Gao et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Gao, Fei
Ye, Qifa
Wan, Qiquan
Liu, Shan
Zhou, Jiandang
Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection
title Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection
title_full Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection
title_fullStr Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection
title_full_unstemmed Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection
title_short Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection
title_sort distribution and resistance of pathogens in liver transplant recipients with acinetobacter baumannii infection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381901/
https://www.ncbi.nlm.nih.gov/pubmed/25848296
http://dx.doi.org/10.2147/TCRM.S82251
work_keys_str_mv AT gaofei distributionandresistanceofpathogensinlivertransplantrecipientswithacinetobacterbaumanniiinfection
AT yeqifa distributionandresistanceofpathogensinlivertransplantrecipientswithacinetobacterbaumanniiinfection
AT wanqiquan distributionandresistanceofpathogensinlivertransplantrecipientswithacinetobacterbaumanniiinfection
AT liushan distributionandresistanceofpathogensinlivertransplantrecipientswithacinetobacterbaumanniiinfection
AT zhoujiandang distributionandresistanceofpathogensinlivertransplantrecipientswithacinetobacterbaumanniiinfection